Maverick's Update

Is Jamie Dimon just like Beyoncé? The comparison may seem like a stretch. But they are both dominating their respective news cycles right now; one is an international “superpowered musical machine” and one is an internationally-recognized finance superpower who is single-handedly shining a spotlight on the economic consequences of the U.S. defaulting on its debt. Health policy has its own rock stars, but they influence specific segments or certain discussions — there is no Jamie Dimon or Beyoncé of health care policy. It is more like a group of scholarly, experienced people playing a 23-year-long game of tag. We explain in the One Thoughtful Paragraph.

Other games people play on the digital health playground:

• Another week, another set of announcements that someone, somewhere, will try to regulate artificial intelligence, but they are not quite there yet: The White House Office of Management and Budget; the National Science Foundation; the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency, the FDA.
• Modern Healthcare identified seven digital health “unicorns” that are struggling despite a lot of money and early confidence placed in them: Cerebral, TruePill, Olive AI, Pear Therapeutics, Elemy, Talkspace, Akili Interactive.
• In the 1960’s, Dustin Hoffman’s character in The Graduate was told that his best money-making future was in plastics. The future of money-making for digital health companies is “channel partners” according to a new playbook from venture capital firm Andreessen Horowitz (“a16z”).

One Thoughtful Paragraph